NexEos Diagnostics, Inc.

Biotechnology company · Chester Springs, Pennsylvania, United States

NexEos Diagnostics, Inc. is a biotechnology company headquartered in Chester Springs, Pennsylvania, United States. Its earliest recorded incorporation is in 2019. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $890,560 in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2026.

www.nexeosdx.comProfile compiled from public records. Is this your company? Request a correction or update

NexEos Diagnostics at a glance

Typebiotechnology company
HeadquartersChester Springs, Pennsylvania, United States
Earliest incorporation on record2019
Employees (per SBIR records)6
SEC CIK1783828

What does NexEos Diagnostics do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $890,560 in total (2020 to 2021). NIH funding came from the National Institute of Allergy and Infectious Diseases.

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $3 million sold (2026).

Frequently asked questions about NexEos Diagnostics

Where is NexEos Diagnostics headquartered?

NexEos Diagnostics, Inc. is headquartered in Chester Springs, Pennsylvania, United States.

What does NexEos Diagnostics do?

NexEos Diagnostics, Inc. is a biotechnology company.

When was NexEos Diagnostics founded?

The earliest incorporation on record for NexEos Diagnostics, Inc. is in 2019, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.